Radiation recall dermatitis induced by edatrexate in a patient with breast cancer

Edith A. Perez, David L. Campbell, Janice K. Ryu

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Enhancement of radiation injury to the skin and mucous membranes has been observed with a number of chemotherapeutic agents. A 32-year-old woman with metastatic breast cancer received local radiation therapy to the lumbosacral area. Six weeks later, systemic edatrexate therapy was initiated and a localized painful erythema with edema and a vesicular eruption occurred over the previous site of radiation therapy. Physicians should be aware that edatrexate can cause radiation recall, and that careful use of anti-inflammatory agents may allow continued chemotherapy treatment.

Original languageEnglish (US)
Pages (from-to)604-607
Number of pages4
JournalCancer Investigation
Volume13
Issue number6
DOIs
StatePublished - 1995
Externally publishedYes

Fingerprint

Radiodermatitis
Radiotherapy
Breast Neoplasms
Radiation Injuries
Erythema
Edema
Mucous Membrane
Anti-Inflammatory Agents
Radiation
Physicians
Drug Therapy
Skin
Therapeutics
edatrexate

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Radiation recall dermatitis induced by edatrexate in a patient with breast cancer. / Perez, Edith A.; Campbell, David L.; Ryu, Janice K.

In: Cancer Investigation, Vol. 13, No. 6, 1995, p. 604-607.

Research output: Contribution to journalArticle

Perez, Edith A. ; Campbell, David L. ; Ryu, Janice K. / Radiation recall dermatitis induced by edatrexate in a patient with breast cancer. In: Cancer Investigation. 1995 ; Vol. 13, No. 6. pp. 604-607.
@article{957e5dc09f0641c598d3cf3872d43ccb,
title = "Radiation recall dermatitis induced by edatrexate in a patient with breast cancer",
abstract = "Enhancement of radiation injury to the skin and mucous membranes has been observed with a number of chemotherapeutic agents. A 32-year-old woman with metastatic breast cancer received local radiation therapy to the lumbosacral area. Six weeks later, systemic edatrexate therapy was initiated and a localized painful erythema with edema and a vesicular eruption occurred over the previous site of radiation therapy. Physicians should be aware that edatrexate can cause radiation recall, and that careful use of anti-inflammatory agents may allow continued chemotherapy treatment.",
author = "Perez, {Edith A.} and Campbell, {David L.} and Ryu, {Janice K.}",
year = "1995",
doi = "10.3109/07357909509024929",
language = "English (US)",
volume = "13",
pages = "604--607",
journal = "Cancer Investigation",
issn = "0735-7907",
publisher = "Informa Healthcare",
number = "6",

}

TY - JOUR

T1 - Radiation recall dermatitis induced by edatrexate in a patient with breast cancer

AU - Perez, Edith A.

AU - Campbell, David L.

AU - Ryu, Janice K.

PY - 1995

Y1 - 1995

N2 - Enhancement of radiation injury to the skin and mucous membranes has been observed with a number of chemotherapeutic agents. A 32-year-old woman with metastatic breast cancer received local radiation therapy to the lumbosacral area. Six weeks later, systemic edatrexate therapy was initiated and a localized painful erythema with edema and a vesicular eruption occurred over the previous site of radiation therapy. Physicians should be aware that edatrexate can cause radiation recall, and that careful use of anti-inflammatory agents may allow continued chemotherapy treatment.

AB - Enhancement of radiation injury to the skin and mucous membranes has been observed with a number of chemotherapeutic agents. A 32-year-old woman with metastatic breast cancer received local radiation therapy to the lumbosacral area. Six weeks later, systemic edatrexate therapy was initiated and a localized painful erythema with edema and a vesicular eruption occurred over the previous site of radiation therapy. Physicians should be aware that edatrexate can cause radiation recall, and that careful use of anti-inflammatory agents may allow continued chemotherapy treatment.

UR - http://www.scopus.com/inward/record.url?scp=0028846266&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028846266&partnerID=8YFLogxK

U2 - 10.3109/07357909509024929

DO - 10.3109/07357909509024929

M3 - Article

C2 - 7583710

AN - SCOPUS:0028846266

VL - 13

SP - 604

EP - 607

JO - Cancer Investigation

JF - Cancer Investigation

SN - 0735-7907

IS - 6

ER -